Skip to main content

08-06-2021 | Rheumatology | News | Article


​​​​​​​EULAR issues recommendations on intra-articular therapies

Author: Claire Barnard

medwireNews: EULAR has developed evidence-based recommendations on the use of intra-articular therapy (IAT) in adult patients with peripheral arthropathies.

The authors say that there is “wide variation” in the use and delivery of IAT – such as glucocorticoids, local anesthetics, and hyaluronic acid – in this population, and these guidelines are “the first evidence and expert opinion-based recommendations to guide health professionals using IAT.”

The guidance was developed by an international multidisciplinary taskforce led by Jacqueline Uson, from Universitario Móstoles in Madrid, Spain. The team has issued recommendations on a number of points, including patient information, antiseptic care, efficacy and safety of repeated injections, safety in special populations, use of local anesthetics, and aftercare.

Uson and co-authors say their guidelines “assume that ‘best practice’ is the rationale for IAT and for the selection of the compound,” and caution that “the efficacy and safety of the specific IATs [and] indications for the different arthropathies” were outside the scope of the recommendations.

They also note that “this project was carried out before the COVID-19 pandemic outbreak, so it does not include specific safety measures to prevent SARS-CoV-2 viral infection nor measures to be used when having to deliver IAT to patients with COVID-19.”

The recommendations are published in the Annals of the Rheumatic Diseases.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

8 June 2021: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.

Ann Rheum Dis 2021; doi:10.1136/annrheumdis-2021-220266